We are live on ! Find out more
SPC

Slate Path Capital Portfolio holdings

AUM $6.73B
1-Year Est. Return 95.97%
This Fund
S&P 500
This Quarter Est. Return
-21.63%
1 Year Est. Return
+95.97%
3 Year Est. Return
+272.8%
5 Year Est. Return
+330.15%
10 Year Est. Return
+4,591.92%
AUM
$1.3B
AUM Growth
-$553M
Cap. Flow
-$90.5M
Cap. Flow %
-6.94%
Top 10 Hldgs %
85.39%
Holding
34
New
7
Increased
6
Reduced
9
Closed
8

Top Buys

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$207M
2
PAAS icon
Pan American Silver
PAAS
+$17.2M
3
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$15.7M
4
ENDP
Endo International plc
ENDP
+$15.3M
5
MOS icon
The Mosaic Company
MOS
+$7.21M

Top Sells

Rank Stock Value
1
SNAP icon
Snap
SNAP
+$75.5M
2
MDCO
Medicines Co
MDCO
+$69.5M
3
EQT icon
EQT Corp
EQT
+$54.2M
4
SBSW icon
Sibanye-Stillwater
SBSW
+$39.1M
5
Z icon
Zillow
Z
+$35.8M

Sector Composition

Rank Sector Weight
1 Communication Services 37.94%
2 Materials 28.45%
3 Healthcare 27.34%
4 Industrials 4.32%
5 Consumer Discretionary 0.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
B
1
Barrick Mining
B
$61.5B
$186M 14.25%
10,145,000
+350,000
+4% +$6.56M
CHTR icon
2
Charter Communications
CHTR
$17.3B
$164M 12.58%
376,000
-5,000
-1% -$2.45M
VTRS icon
3
Viatris
VTRS
$20.4B
$161M 12.33%
+10,785,000
New +$207M
NYT icon
4
New York Times
NYT
$12.1B
$133M 10.2%
4,330,000
-600,000
-12% -$20.6M
SNAP icon
5
Snap
SNAP
$7.89B
$114M 8.74%
9,585,000
-4,920,000
-34% -$75.5M
ALNY icon
6
Alnylam Pharmaceuticals
ALNY
$27.5B
$78.2M 5.99%
718,000
-97,000
-12% -$11.2M
Z icon
7
Zillow
Z
$7.79B
$77.4M 5.94%
2,150,000
-775,000
-26% -$35.8M
MOS icon
8
The Mosaic Company
MOS
$7.03B
$70.8M 5.43%
6,545,000
+425,000
+7% +$7.21M
BHC icon
9
Bausch Health
BHC
$2.57B
$65.8M 5.05%
4,245,000
-1,334,948
-24% -$32.2M
PAAS icon
10
Pan American Silver
PAAS
$18.2B
$63.5M 4.87%
4,430,000
+830,000
+23% +$17.2M
KEX icon
11
Kirby Corp
KEX
$7.01B
$56.3M 4.32%
1,296,000
-197,000
-13% -$13.4M
FCX icon
12
Freeport-McMoran
FCX
$90B
$50.8M 3.9%
7,530,000
+550,000
+8% +$5.75M
IRWD icon
13
Ironwood Pharmaceuticals
IRWD
$696M
$13.5M 1.04%
+1,340,000
New +$15.7M
ENDP
14
DELISTED
Endo International plc
ENDP
$12.5M 0.96%
3,380,000
+3,030,000
+866% +$15.3M
CUE icon
15
Cue Biopharma
CUE
$113M
$12.4M 0.95%
29,023
-644
-2% -$312K
EEM icon
16
CALL
iShares MSCI Emerging Markets ETF
EEM
$28.8B
$11.4M 0.87%
333,000
– –
QURE icon
17
uniQure
QURE
$3.03B
$6.64M 0.51%
140,000
– –
ZG icon
18
Zillow
ZG
$7.94B
$6.28M 0.48%
185,000
– –
LX
19
LexinFintech Holdings
LX
$241M
$3.9M 0.3%
440,000
+215,000
+96% +$2.66M
W icon
20
Wayfair
W
$11.2B
$3.74M 0.29%
+70,000
New +$5.36M
APRN
21
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$3.58M 0.27%
24,750
-1,917
-7% -$122K
ATRA icon
22
Atara Biotherapeutics
ATRA
$75.5M
$3.57M 0.27%
+16,800
New +$5.33M
CYCN icon
23
Cyclerion Therapeutics
CYCN
$14.9M
$3.17M 0.24%
+59,803
New +$4.27M
I
24
DELISTED
INTELSAT S. A.
I
$1.68M 0.13%
1,100,000
– –
RIG icon
25
Transocean
RIG
$5.89B
$545K 0.04%
+470,000
New +$1.83M
1
2

Similar funds

SPS
Susquehanna Portfolio Strategies Bala Cynwyd, Pennsylvania $6.73B AUM 45.57% 1-Year Est. Return
BHM
Briar Hall Management Nashville, Tennessee $6.72B AUM 4.95% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
CIMLRA
CBRE Investment Management Listed Real Assets Radnor, Pennsylvania $6.75B AUM 8.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $6.76B AUM 88.1% 1-Year Est. Return
MSE
MUFG Securities EMEA London, United Kingdom $6.7B AUM 32.3% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Slate Path Capital's Q1 2020 Portfolio in Review

As of Q1 2020, Slate Path Capital held 34 positions worth $1.3B, down 30% from $1.86B the previous quarter. Its ten largest holdings account for 85% of the portfolio.

Slate Path Capital withdrew a net $90.5M in Q1 2020, closing 8 positions and reducing 9 holdings. Its most notable exit was Medicines Co, an estimated $69.5M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 38% of assets, down from 39% a quarter earlier, followed by Materials and Healthcare.

Against the trend, Slate Path Capital opened a new position in Viatris worth $161M.

  • Slate Path Capital's largest Q1 2020 buy was Viatris: 10,785,000 shares worth $161M.
  • Slate Path Capital added most to Pan American Silver in Q1 2020, an estimated $17.2M increase.
  • Slate Path Capital's biggest Q1 2020 reduction was Snap, cutting an estimated $75.5M.
  • Slate Path Capital fully exited Medicines Co in Q1 2020, selling an estimated $69.5M.
  • Slate Path Capital's ten largest holdings make up 85% of its $1.3B portfolio in Q1 2020.
  • Slate Path Capital opened 7 new positions and closed 8 in Q1 2020.
  • Slate Path Capital's portfolio value fell 30% quarter-over-quarter to $1.3B.

Based on Slate Path Capital's 13F filing for Q1 2020, filed 15 May 2020.